Saiyad Sarkar, MD
Pulmonary Disease · Baltimore, MDNPI 1689654824
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (44.5%), education and travel and lodging — rather than concentrated in one kind of arrangement. 8 manufacturers reported payments, led by Noah Medical Corporation at 55.4% of the total. Among pulmonary disease clinicians in MD with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 85 payments — averaging $407.55 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Noah Medical Corporation$19K
- Merit Medical Systems Inc$8K
- Intuitive Surgical$7K
- Pulmonx Corporation$195
- Galvanize Therapeutics, Inc$137
- Olympus America Inc.$59
- plus $24 from 2 others
What the payments were for
- Consulting fees$15,42045%
- Travel & lodging$7,79022%
- Food & beverage$3,0079%
- Education$8,42524%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Noah Medical Corporation | 22 | $19,179 |
| Merit Medical Systems Inc | 6 | $8,142 |
| Intuitive Surgical | 49 | $6,906 |
| Pulmonx Corporation | 3 | $195 |
| Galvanize Therapeutics, Inc | 2 | $137 |
| Olympus America Inc. | 1 | $59 |
| Baxter Healthcare | 1 | $13 |
| Covidien LP | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- GALAXY$15,814
- AEROmini Stent$4,932
- Da Vinci Surgical System$3,098
- ION$3,000
- AEROSIZER Tracheobronchial Stent Sizing Device$1,950
- ALIYA SYSTEM$119
- CHARTIS CATHETER$117
- ZEPHYR DELIVERY CATHETER$117
- ZEPHYR ENDOBRONCHIAL VALVE$117
- PULMONX CHARTIS TABLET CONSOLE$117
How this compares
$34,642 in reported general payments places this provider in the 90th percentile of 297 pulmonary disease providers in Maryland.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 60 | $60,242 |
| Anoro ElliptaUmeclidinium Brm/Vilanterol Tr | 28 | $12,285 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 39 | $785 |
Paid to pharmacies, not to this prescriber.
Other pulmonary disease in Baltimore
- Alan SchwartzBaltimore$1.3M
- Hitesh BatraBaltimore$611K
- Lonny YarmusBaltimore$582K
- Robert WiseBaltimore$389K
- Ko Pen WangBaltimore$280K
- Hans LeeBaltimore$277K
- Angela ArgentoBaltimore$269K
- Michael DrummondBaltimore$263K
- Jason AkulianBaltimore$231K
- Kathryn RobinettBaltimore$160K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.